SA
Sign upLog In

Vertex Pharmaceuticals (VRTX)

Operating Expenses

$5.99B

TTM · Period ending: · USD

VRTX logo

VRTX Operating Expenses

Latest reported$5.99B
VRTX TTM Operating Expenses (-$6.40M → $5.99B)
High-resolution chart · PNG

VRTX operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
128,533,000
119,155,000
112,727,000
114,484,000
108,779,000
106,087,000
104,500,000
101,400,000
98,500,000
90,500,000
81,300,000
74,600,000
73,200,000
69,500,000
66,400,000
58,700,000
49,600,000
47,700,000
46,300,000
46,800,000
47,000,000
52,200,000
52,300,000
52,900,000
52,700,000
46,300,000
44,000,000
42,400,000
39,500,000
34,900,000
30,400,000
24,500,000
20,600,000
15,400,000
13,800,000
12,200,000
10,500,000
11,800,000
8,200,000
-1,200,000
-3,800,000
-6,400,000
-6,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.